Ignite Creation Date:
2024-05-06 @ 6:08 PM
Last Modification Date:
2024-10-26 @ 2:42 PM
Study NCT ID:
NCT05551936
Status:
RECRUITING
Last Update Posted:
2024-06-05
First Post:
2022-09-19
Brief Title:
A Study of Tazemetostat With Rituximab and Abbreviated Bendamustine in the Frontline Treatment of High Tumor Burden Follicular Lymphoma
Sponsor:
Organization:
Big Ten Cancer Research Consortium